Aelis Farma S.A.
AELIS.PA · PAR
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | €0 | €0 | €0 | €0 |
| - Cash | €0 | €0 | €0 | €0 |
| + Debt | €0 | €0 | €0 | €0 |
| Enterprise Value | €0 | €0 | €0 | €0 |
| Revenue | €0 | €0 | €0 | €0 |
| % Growth | -37.8% | -65.1% | -22.5% | – |
| Gross Profit | €0 | €0 | €0 | €0 |
| % Margin | 100% | 100% | 100% | 125.1% |
| EBITDA | -€0 | -€0 | -€0 | -€0 |
| % Margin | -458.5% | -310% | -85.8% | -74.5% |
| Net Income | -€0 | -€0 | -€0 | -€0 |
| % Margin | -483% | -269.3% | -86.9% | -64.8% |
| EPS Diluted | -0.32 | -0.28 | -0.27 | -0.26 |
| % Growth | -14.3% | -3.7% | -3.8% | – |
| Operating Cash Flow | -€0 | -€0 | -€0 | -€0 |
| Capital Expenditures | -€0 | -€0 | -€0 | -€0 |
| Free Cash Flow | -€0 | -€0 | -€0 | -€0 |